Aspira Women’s Health Reports Fourth Quarter and Full Year 2021 Financial Results – Benzinga

Aspira Women’s Health Reports Fourth Quarter and Full Year 2021 Financial Results – Benzinga

Total Revenue Increased 46% to $6.8 million; OVA1 Volume Grew 28% to 17,359 Units Exercise of option in the Harvard Dana-Farber Cancer Institute Collaboration Leadership and Board appointments implemented in First